Arvee Laboratories.
+91-2717-430479
info@arveelabs.com
https://www1.nseindia.com/emerge/index_sme.htm
Delivering Quality, Thinking Safety, Preserving Nature
  • Home
  • About Us
    • Mission & Vision
    • Infrastructure
    • Team
    • Delivering Quality
    • Thinking Safety
    • Preserving Nature
  • Products
    • Polymer Modifiers
    • Dimethyl 5-Sodiosulfoisophthalate
    • 5-Sulfoisophthalic Acid Mono Sodium Salt
    • 5-Sulfoisophthalic Acid Mono Lithium Salt
    • 5-Sodiosulfo-Bis-(β-Hydroxyethyl)-Isophthalate
    • Contrast Media Intermediates
    • 5-Nitroisophthalic acid
    • Dimethyl 5-Nitroisophthalate
    • Monomethyl 5-Nitroisophthalate
    • 5-Hydroxyisophthalic acid
    • 5-Aminoisophthalic acid
    • Dimethyl 5-Aminoisophthalate
    • 3,5-Dinitrobenzoic Acid
    • 3,5-Diamino Benzoic Acid
    • Drug Intermediates
    • 2-Acetyl Thiophene
    • Thiophene-2-Carboxaldehyde
    • 4–Amino Pyridine
    • 2–Chloro–5–Nitrobenzoic Acid
  • Investor Corner
    • CODE OF CONDUCT
    • CORPORATE GOVERNANCE >
      • BOARD OF DIRECTORS
      • COMMITTEES
      • CORPORATE GOVERNANCE REPORT
    • ANNUAL SECRETARIAL COMPLIANCE
    • FINANCIAL INFORMATION>
      • ANNUAL RESULTS
      • QUARTERLY RESULTS
      • NOTICE FOR ANNUAL GENERAL MEETING
      • NOTICE FOR BOARD MEETING
    • INVESTOR GRIEVANCE
    • SHAREHOLDING PATTERN
    • ANNOUNCEMENTS >
      • ANNUAL GENERAL MEETING
      • BOARD MEETING
      • EXTRAORDINARY GENERAL MEETING
      • VOTING RESULTS & SCRUTINIZER'S REPORT
    • PROSPECTUS
    • UPDATES AND NEWS
    • REGISTRAR AND SHARE TRANSFER AGENT
    • TRADING WINDOW
    • RESULTS PUBLICATION
    • PUBLICATION OF NOTICES GIVEN
      TO SHAREHOLDERS
    • EXTRACT OF ANNUAL RETURN
  • Research
  • Career
  • Contact Us

/// Investor Corner

  • CODE OF CONDUCT
  • CORPORATE GOVERNANCE
    • BOARD OF DIRECTORS
    • COMMITTEES
    • CORPORATE GOVERNANCE REPORT
  • ANNUAL SECRETARIAL COMPLIANCE
  • FINANCIAL INFORMATION
    • ANNUAL RESULTS
    • QUARTERLY RESULTS
    • NOTICE FOR ANNUAL GENERAL MEETING
    • NOTICE FOR BOARD MEETING
  • INVESTOR GRIEVANCE
  • SHAREHOLDING PATTERN
  • ANNOUNCEMENTS
    • ANNUAL GENERAL MEETING
    • BOARD MEETING
    • EXTRAORDINARY GENERAL MEETING
    • VOTING RESULTS & SCRUTINIZER'S REPORT
  • PROSPECTUS
  • UPDATES AND NEWS
    • OTHER UPDATES
    • CLAUSE 40 DISCLOSURE
    • CLAUSE 74(5) DISCLOSURE
  • REGISTRAR AND SHARE TRANSFER AGENT
  • TRADING WINDOW
  • RESULTS PUBLICATION
  • PUBLICATION OF NOTICES GIVEN
    TO SHAREHOLDERS
  • EXTRACT OF ANNUAL RETURN
PROSPECTUS

Demat Audit & Reco of Share Capital Audit 30-06-2022

Consent Letter cum appointment of Statutoty Auditor

Consent Letter of Internal Auditor for FY 22-23

Resignation letter from CA Jaimin Deliwala

Resignation of Independent Director Vishal Mehta

Demat Audit & Reconciliation of Share Capital Audit 31-03-2022

Large Entity Disclosure for 2021-22

Demat Audit & Reconciliation of Share Capital Audit 31-12-2021

Demat Audit & Reconciliation of Share Capital Audit 30-09-2021

LETTER FOR CHANGE IN STATUTORY AUDITOR FROM 1ST JULY 2021

Demat Audit & Reconciliation of Share Capital Audit 30-06-2021

Demat Audit & Reconciliation of Share Capital Audit 31-03-2021

Clause 74(5) Disclosure 31st March 2021

Clause 40 Disclosure 31st March 2021

Large Entity Disclosure

Letter for change in Directors'remuneration

CFO APPOINTMENT

CFO RESIGNATION

Auditors letter for change in Statutory Auditors

Demat Audit & Reconciliation of Share Capital Audit 31-12-2020

Demat Audit & Reconciliation of Share Capital Audit 30-09-2020

Demat Audit & Reconciliation of Share Capital Audit 30-06-2020

Demat Audit & Reconciliation of Share Capital Audit 31-03-2020

Demat Audit & Reconciliation of Share Capital Audit 31-12-2019

Demat Audit & Reconciliation of Share Capital Audit 30-09-2019

Demat Audit & Reconciliation of Share Capital Audit 30-06-2019

Demat Audit & Reconciliation of Share Capital Audit 31-03-2019

Demat Audit & Reconciliation of Share Capital Audit 31-12-2018

Demat Audit & Reconciliation of Share Capital Audit 30-09-2018

Demat Audit & Reconciliation of Share Capital Audit 30-06-2018

Demat Audit & Reconciliation of Share Capital Audit 31-03-2018

Letter for change in Directors' remuneration

/// Corporate Office

Arvee Laboratories (India) Limited

403, Entice Building,
Opposite Jayantilal Park BRTS Bus Stop,
Iskcon – Bopal Road, Ambli,
Ahmedabad 380 058, Gujarat, India.

Phone: +91- 2717-430479
+91- 2717-410819
Email: info@arveelabs.com

/// Factory/Works

Arvee Laboratories (India) Limited

Survey No. 316, Bhavnagar-Sihor Road
Navagam (Kardej), Post Vartej - 364060,
Bhavnagar, Gujarat, India

Phone: +91-2717-430479
+91-2717-410819
Email: info@arveelabs.com

/// Stay In Touch

Find out what's happening:

Copyright © 2008-2023, Arvee Laboratories (India) Limited. All Rights Reserved.